株式会社スカイライト・バイオテック

Acquired

Skylight Biotech provides solutions for research, prevention and diagnosis in lifestyle-related diseases.

What it does

"Skylight Biotech is a leading Insurtech company specializing in solutions for research, prevention, and diagnosis of lifestyle-related diseases. Through their preventive healthcare support services, Skylight Biotech conducts research and provides testing services for new biomarkers that assess the risk of metabolic syndrome and atherosclerosis in self-paying patients. Their flagship testing service, MetaboCHART, offers precise analysis of small LDL particles in health check-ups, enabling early detection of metabolic syndrome and atherosclerosis risk based on data on "ultra-bad cholesterol" and LDL particle size. By quantifying previously challenging data on "ultra-bad cholesterol" and particle size, Skylight Biotech's detailed analysis aids in risk assessment and is presented in a chart format for patients. Skylight Biotech's innovative approach to disease prevention and early detection contributes significantly to the healthcare industry's advancement."

Its site says now · captured 2026-08-23

�Ђ��ɃT�v�������g�y�l�C�����L���O�z

���‚܂ł����C�ɎU�����y���݂����Ƃ������X�ɑI�΂�Ă���w�v���e�I�O���J���A�l�r�l�A�O���R�T�~���A�R���h���C�`���Ȃǁx�̏ڍׂ�����������L���O���܂��B

Next to it in Healthcare and bio · metabolic disease diagnostics

  • Una HealthPlug and Play

    The most effective Digital Therapy to reverse metabolic dysfunction based on mobile technology, biosensors, AI and behavioral science.

  • Probably GeneticY Combinator W19

    Patient Intelligence Platform for Genetic Disease

  • ACCELStars, Inc.Plug and Play

    The University of Tokyo Medical! Sleep with the world's highest accuracy with arm-mounted equipment-Captures awakening, and discover, treat, and prevent brain and mental illness. / 東大医発!腕装着機器で世界最高精度の技術で睡眠-覚醒を捉え、脳と心の病気等を早期発見・治療・予防する

  • HA-PPY Co., LtdPlug and Play

    Provision of devices and AI・IoT related to healthcare

  • アイリス株式会社Plug and Play

    Aillis specializes in the development of testing methods for Influenza using artificial intelligence technology.

  • Axion ResearchPlug and Play

    Our solution is to analyze the presymptomatic phase of diseases and/or to predict and estimate disease risk using our hybrid AI engine.

  • CYBOPlug and Play

    CYBO provides products and services to understand cells deeply and to harness them widely.

  • daslabPlug and Play

    Engineering digital diagnostics of the future